Multiple sclerosis (MS) is a progressive neurological disorder affecting between 2 and 2.5
million people globally. Tests of mobility form part of clinical assessments of MS. Quantitative …

Walking limitation is a key component of disability in patients with multiple sclerosis (MS),
but the information on daily walking activity and disability over time is limited. To …

Inertial measurement units (IMUs) allow accurate quantification of gait impairment of people
with multiple sclerosis (pwMS). Nonetheless, it is not clear how IMU-based metrics might be …

Background There has been increased interest in objectively quantifying time spent in
moderate-to-vigorous physical activity (MVPA) using accelerometry as an outcome among …

This pilot study investigated the test-retest reliability of an RT3 accelerometer (RT3) for
measuring motion in people with multiple sclerosis (MS). Ten people with MS (mean age 49 …

Subtle gait and balance dysfunction is a precursor to loss of mobility in multiple sclerosis
(MS). Biomechanical assessments using advanced gait and balance analysis technologies …

Disability measures in multiple sclerosis (MS) rely heavily on ambulatory function, and
current metrics fail to capture potentially important variability in walking behavior. We sought …

The aim of this work was to determine whether wearable inertial measurement units (IMUs)
could detect gait improvements across different disability groups of people with Multiple …

Background Multiple sclerosis (MS) is a disabling disease affecting the central nervous
system and consequently the whole body's functional systems resulting in different gait …

Background Ambulatory disability is common in people with multiple sclerosis (MS). Remote
monitoring using average daily step count (STEPS) can assess physical activity (activity) …